ESC 365 - Association of ticagrelor vs clopidogrel with net adverse clinical events in STEMI patients with mild thrombocytopenia

ESC Professional Premium Access

Association of ticagrelor vs clopidogrel with net adverse clinical events in STEMI patients with mild thrombocytopenia

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Topic: Clinical

Speaker: Professor K. Chen (Tianjin, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

0 follower

6 more presentations in this session

Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II

Speaker: Doctor T. Gu (Tianjin, CN)

Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial

Speaker: Ms M. Lin (Hong Kong, HK)

Exploring the long-term effects of dapagliflozin in patients with stable acute myocardial infarction and preserved ejection fraction through a propensity score matching study

Speaker: Doctor B. Hsiao (Taipei, TW)

Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials

Speaker: Professor J. Carson (New Brunswick, US)

CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats

Speaker: Professor Y. Wang (Kunming, CN)

Access the full session

Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Speakers: Professor K. Chen, Doctor T. Gu, Ms M. Lin, Doctor B. Hsiao, Professor J. Carson...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources